Amiodarone is an antiarrhythmic medication that affects the rhythm of heartbeats.Amiodarone is used to help keep the heart beating normally in people with life-threatening heart rhythm disorders of the ventricles (the lower chambers of the heart that allow blood to flow out of the heart). Amiodarone is used to treat or prevent ventricular tachycardia or ventricular fibrillation.

The global Amiodarone Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Amiodarone Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Amiodarone Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Amiodarone Injection include Baxter, AuroMedics, Fresenius Kabi, Hikma, Mylan, Sagent, Bioniche Pharma, Sanofi and Prism Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Amiodarone Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amiodarone Injection.

Report Scope

The Amiodarone Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amiodarone Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Amiodarone Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Amiodarone Injection Market Report

Report Metric	Details
Report Name	Amiodarone Injection Market
Segment by Type	15mg/ml 50mg/ml
Segment by Application	Hospital Clinics Recovery Center
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Baxter, AuroMedics, Fresenius Kabi, Hikma, Mylan, Sagent, Bioniche Pharma, Sanofi, Prism Pharmaceutical, Fangming Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amiodarone Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amiodarone Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Amiodarone Injection Market report?

Ans: The main players in the Amiodarone Injection Market are Baxter, AuroMedics, Fresenius Kabi, Hikma, Mylan, Sagent, Bioniche Pharma, Sanofi, Prism Pharmaceutical, Fangming Pharmaceutical Group

What are the Application segmentation covered in the Amiodarone Injection Market report?

Ans: The Applications covered in the Amiodarone Injection Market report are Hospital, Clinics, Recovery Center

What are the Type segmentation covered in the Amiodarone Injection Market report?

Ans: The Types covered in the Amiodarone Injection Market report are 15mg/ml, 50mg/ml

1 Amiodarone Injection Market Overview

1.1 Product Overview and Scope of Amiodarone Injection

1.2 Amiodarone Injection Segment by Type

1.2.1 Global Amiodarone Injection Market Value Comparison by Type (2024-2030)

1.2.2 15mg/ml

1.2.3 50mg/ml

1.3 Amiodarone Injection Segment by Application

1.3.1 Global Amiodarone Injection Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Recovery Center

1.4 Global Amiodarone Injection Market Size Estimates and Forecasts

1.4.1 Global Amiodarone Injection Revenue 2019-2030

1.4.2 Global Amiodarone Injection Sales 2019-2030

1.4.3 Global Amiodarone Injection Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Amiodarone Injection Market Competition by Manufacturers

2.1 Global Amiodarone Injection Sales Market Share by Manufacturers (2019-2024)

2.2 Global Amiodarone Injection Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Amiodarone Injection Average Price by Manufacturers (2019-2024)

2.4 Global Amiodarone Injection Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Amiodarone Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Amiodarone Injection, Product Type & Application

2.7 Amiodarone Injection Market Competitive Situation and Trends

2.7.1 Amiodarone Injection Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Amiodarone Injection Players Market Share by Revenue

2.7.3 Global Amiodarone Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Amiodarone Injection Retrospective Market Scenario by Region

3.1 Global Amiodarone Injection Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Amiodarone Injection Global Amiodarone Injection Sales by Region: 2019-2030

3.2.1 Global Amiodarone Injection Sales by Region: 2019-2024

3.2.2 Global Amiodarone Injection Sales by Region: 2025-2030

3.3 Global Amiodarone Injection Global Amiodarone Injection Revenue by Region: 2019-2030

3.3.1 Global Amiodarone Injection Revenue by Region: 2019-2024

3.3.2 Global Amiodarone Injection Revenue by Region: 2025-2030

3.4 North America Amiodarone Injection Market Facts & Figures by Country

3.4.1 North America Amiodarone Injection Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Amiodarone Injection Sales by Country (2019-2030)

3.4.3 North America Amiodarone Injection Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Amiodarone Injection Market Facts & Figures by Country

3.5.1 Europe Amiodarone Injection Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Amiodarone Injection Sales by Country (2019-2030)

3.5.3 Europe Amiodarone Injection Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Amiodarone Injection Market Facts & Figures by Country

3.6.1 Asia Pacific Amiodarone Injection Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Amiodarone Injection Sales by Country (2019-2030)

3.6.3 Asia Pacific Amiodarone Injection Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Amiodarone Injection Market Facts & Figures by Country

3.7.1 Latin America Amiodarone Injection Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Amiodarone Injection Sales by Country (2019-2030)

3.7.3 Latin America Amiodarone Injection Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Amiodarone Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Amiodarone Injection Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Amiodarone Injection Sales by Country (2019-2030)

3.8.3 Middle East and Africa Amiodarone Injection Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Amiodarone Injection Sales by Type (2019-2030)

4.1.1 Global Amiodarone Injection Sales by Type (2019-2024)

4.1.2 Global Amiodarone Injection Sales by Type (2025-2030)

4.1.3 Global Amiodarone Injection Sales Market Share by Type (2019-2030)

4.2 Global Amiodarone Injection Revenue by Type (2019-2030)

4.2.1 Global Amiodarone Injection Revenue by Type (2019-2024)

4.2.2 Global Amiodarone Injection Revenue by Type (2025-2030)

4.2.3 Global Amiodarone Injection Revenue Market Share by Type (2019-2030)

4.3 Global Amiodarone Injection Price by Type (2019-2030)

5 Segment by Application

5.1 Global Amiodarone Injection Sales by Application (2019-2030)

5.1.1 Global Amiodarone Injection Sales by Application (2019-2024)

5.1.2 Global Amiodarone Injection Sales by Application (2025-2030)

5.1.3 Global Amiodarone Injection Sales Market Share by Application (2019-2030)

5.2 Global Amiodarone Injection Revenue by Application (2019-2030)

5.2.1 Global Amiodarone Injection Revenue by Application (2019-2024)

5.2.2 Global Amiodarone Injection Revenue by Application (2025-2030)

5.2.3 Global Amiodarone Injection Revenue Market Share by Application (2019-2030)

5.3 Global Amiodarone Injection Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Baxter

6.1.1 Baxter Corporation Information

6.1.2 Baxter Description and Business Overview

6.1.3 Baxter Amiodarone Injection Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Baxter Amiodarone Injection Product Portfolio

6.1.5 Baxter Recent Developments/Updates

6.2 AuroMedics

6.2.1 AuroMedics Corporation Information

6.2.2 AuroMedics Description and Business Overview

6.2.3 AuroMedics Amiodarone Injection Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AuroMedics Amiodarone Injection Product Portfolio

6.2.5 AuroMedics Recent Developments/Updates

6.3 Fresenius Kabi

6.3.1 Fresenius Kabi Corporation Information

6.3.2 Fresenius Kabi Description and Business Overview

6.3.3 Fresenius Kabi Amiodarone Injection Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Fresenius Kabi Amiodarone Injection Product Portfolio

6.3.5 Fresenius Kabi Recent Developments/Updates

6.4 Hikma

6.4.1 Hikma Corporation Information

6.4.2 Hikma Description and Business Overview

6.4.3 Hikma Amiodarone Injection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Hikma Amiodarone Injection Product Portfolio

6.4.5 Hikma Recent Developments/Updates

6.5 Mylan

6.5.1 Mylan Corporation Information

6.5.2 Mylan Description and Business Overview

6.5.3 Mylan Amiodarone Injection Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Mylan Amiodarone Injection Product Portfolio

6.5.5 Mylan Recent Developments/Updates

6.6 Sagent

6.6.1 Sagent Corporation Information

6.6.2 Sagent Description and Business Overview

6.6.3 Sagent Amiodarone Injection Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Sagent Amiodarone Injection Product Portfolio

6.6.5 Sagent Recent Developments/Updates

6.7 Bioniche Pharma

6.6.1 Bioniche Pharma Corporation Information

6.6.2 Bioniche Pharma Description and Business Overview

6.6.3 Bioniche Pharma Amiodarone Injection Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bioniche Pharma Amiodarone Injection Product Portfolio

6.7.5 Bioniche Pharma Recent Developments/Updates

6.8 Sanofi

6.8.1 Sanofi Corporation Information

6.8.2 Sanofi Description and Business Overview

6.8.3 Sanofi Amiodarone Injection Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Sanofi Amiodarone Injection Product Portfolio

6.8.5 Sanofi Recent Developments/Updates

6.9 Prism Pharmaceutical

6.9.1 Prism Pharmaceutical Corporation Information

6.9.2 Prism Pharmaceutical Description and Business Overview

6.9.3 Prism Pharmaceutical Amiodarone Injection Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Prism Pharmaceutical Amiodarone Injection Product Portfolio

6.9.5 Prism Pharmaceutical Recent Developments/Updates

6.10 Fangming Pharmaceutical Group

6.10.1 Fangming Pharmaceutical Group Corporation Information

6.10.2 Fangming Pharmaceutical Group Description and Business Overview

6.10.3 Fangming Pharmaceutical Group Amiodarone Injection Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Fangming Pharmaceutical Group Amiodarone Injection Product Portfolio

6.10.5 Fangming Pharmaceutical Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Amiodarone Injection Industry Chain Analysis

7.2 Amiodarone Injection Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Amiodarone Injection Production Mode & Process

7.4 Amiodarone Injection Sales and Marketing

7.4.1 Amiodarone Injection Sales Channels

7.4.2 Amiodarone Injection Distributors

7.5 Amiodarone Injection Customers

8 Amiodarone Injection Market Dynamics

8.1 Amiodarone Injection Industry Trends

8.2 Amiodarone Injection Market Drivers

8.3 Amiodarone Injection Market Challenges

8.4 Amiodarone Injection Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Fangming Pharmaceutical Group

List of Tables

Table 1. Global Amiodarone Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Amiodarone Injection Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Amiodarone Injection Market Competitive Situation by Manufacturers in 2023

Table 4. Global Amiodarone Injection Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Amiodarone Injection Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Amiodarone Injection Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Amiodarone Injection Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Amiodarone Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Amiodarone Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Amiodarone Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Amiodarone Injection, Product Type & Application

Table 12. Global Key Manufacturers of Amiodarone Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Amiodarone Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amiodarone Injection as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Amiodarone Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Amiodarone Injection Sales by Region (2019-2024) & (K Units)

Table 18. Global Amiodarone Injection Sales Market Share by Region (2019-2024)

Table 19. Global Amiodarone Injection Sales by Region (2025-2030) & (K Units)

Table 20. Global Amiodarone Injection Sales Market Share by Region (2025-2030)

Table 21. Global Amiodarone Injection Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Amiodarone Injection Revenue Market Share by Region (2019-2024)

Table 23. Global Amiodarone Injection Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Amiodarone Injection Revenue Market Share by Region (2025-2030)

Table 25. North America Amiodarone Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Amiodarone Injection Sales by Country (2019-2024) & (K Units)

Table 27. North America Amiodarone Injection Sales by Country (2025-2030) & (K Units)

Table 28. North America Amiodarone Injection Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Amiodarone Injection Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Amiodarone Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Amiodarone Injection Sales by Country (2019-2024) & (K Units)

Table 32. Europe Amiodarone Injection Sales by Country (2025-2030) & (K Units)

Table 33. Europe Amiodarone Injection Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Amiodarone Injection Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Amiodarone Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Amiodarone Injection Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Amiodarone Injection Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Amiodarone Injection Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Amiodarone Injection Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Amiodarone Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Amiodarone Injection Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Amiodarone Injection Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Amiodarone Injection Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Amiodarone Injection Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Amiodarone Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Amiodarone Injection Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Amiodarone Injection Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Amiodarone Injection Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Amiodarone Injection Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Amiodarone Injection Sales (K Units) by Type (2019-2024)

Table 51. Global Amiodarone Injection Sales (K Units) by Type (2025-2030)

Table 52. Global Amiodarone Injection Sales Market Share by Type (2019-2024)

Table 53. Global Amiodarone Injection Sales Market Share by Type (2025-2030)

Table 54. Global Amiodarone Injection Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Amiodarone Injection Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Amiodarone Injection Revenue Market Share by Type (2019-2024)

Table 57. Global Amiodarone Injection Revenue Market Share by Type (2025-2030)

Table 58. Global Amiodarone Injection Price (US$/Unit) by Type (2019-2024)

Table 59. Global Amiodarone Injection Price (US$/Unit) by Type (2025-2030)

Table 60. Global Amiodarone Injection Sales (K Units) by Application (2019-2024)

Table 61. Global Amiodarone Injection Sales (K Units) by Application (2025-2030)

Table 62. Global Amiodarone Injection Sales Market Share by Application (2019-2024)

Table 63. Global Amiodarone Injection Sales Market Share by Application (2025-2030)

Table 64. Global Amiodarone Injection Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Amiodarone Injection Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Amiodarone Injection Revenue Market Share by Application (2019-2024)

Table 67. Global Amiodarone Injection Revenue Market Share by Application (2025-2030)

Table 68. Global Amiodarone Injection Price (US$/Unit) by Application (2019-2024)

Table 69. Global Amiodarone Injection Price (US$/Unit) by Application (2025-2030)

Table 70. Baxter Corporation Information

Table 71. Baxter Description and Business Overview

Table 72. Baxter Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Baxter Amiodarone Injection Product

Table 74. Baxter Recent Developments/Updates

Table 75. AuroMedics Corporation Information

Table 76. AuroMedics Description and Business Overview

Table 77. AuroMedics Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. AuroMedics Amiodarone Injection Product

Table 79. AuroMedics Recent Developments/Updates

Table 80. Fresenius Kabi Corporation Information

Table 81. Fresenius Kabi Description and Business Overview

Table 82. Fresenius Kabi Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Fresenius Kabi Amiodarone Injection Product

Table 84. Fresenius Kabi Recent Developments/Updates

Table 85. Hikma Corporation Information

Table 86. Hikma Description and Business Overview

Table 87. Hikma Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Hikma Amiodarone Injection Product

Table 89. Hikma Recent Developments/Updates

Table 90. Mylan Corporation Information

Table 91. Mylan Description and Business Overview

Table 92. Mylan Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Mylan Amiodarone Injection Product

Table 94. Mylan Recent Developments/Updates

Table 95. Sagent Corporation Information

Table 96. Sagent Description and Business Overview

Table 97. Sagent Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Sagent Amiodarone Injection Product

Table 99. Sagent Recent Developments/Updates

Table 100. Bioniche Pharma Corporation Information

Table 101. Bioniche Pharma Description and Business Overview

Table 102. Bioniche Pharma Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Bioniche Pharma Amiodarone Injection Product

Table 104. Bioniche Pharma Recent Developments/Updates

Table 105. Sanofi Corporation Information

Table 106. Sanofi Description and Business Overview

Table 107. Sanofi Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Sanofi Amiodarone Injection Product

Table 109. Sanofi Recent Developments/Updates

Table 110. Prism Pharmaceutical Corporation Information

Table 111. Prism Pharmaceutical Description and Business Overview

Table 112. Prism Pharmaceutical Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Prism Pharmaceutical Amiodarone Injection Product

Table 114. Prism Pharmaceutical Recent Developments/Updates

Table 115. Fangming Pharmaceutical Group Corporation Information

Table 116. Fangming Pharmaceutical Group Description and Business Overview

Table 117. Fangming Pharmaceutical Group Amiodarone Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Fangming Pharmaceutical Group Amiodarone Injection Product

Table 119. Fangming Pharmaceutical Group Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Amiodarone Injection Distributors List

Table 123. Amiodarone Injection Customers List

Table 124. Amiodarone Injection Market Trends

Table 125. Amiodarone Injection Market Drivers

Table 126. Amiodarone Injection Market Challenges

Table 127. Amiodarone Injection Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Amiodarone Injection

Figure 2. Global Amiodarone Injection Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Amiodarone Injection Market Share by Type in 2023 & 2030

Figure 4. 15mg/ml Product Picture

Figure 5. 50mg/ml Product Picture

Figure 6. Global Amiodarone Injection Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Amiodarone Injection Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Clinics

Figure 10. Recovery Center

Figure 11. Global Amiodarone Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Amiodarone Injection Market Size (2019-2030) & (US$ Million)

Figure 13. Global Amiodarone Injection Sales (2019-2030) & (K Units)

Figure 14. Global Amiodarone Injection Average Price (US$/Unit) & (2019-2030)

Figure 15. Amiodarone Injection Report Years Considered

Figure 16. Amiodarone Injection Sales Share by Manufacturers in 2023

Figure 17. Global Amiodarone Injection Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Amiodarone Injection Players: Market Share by Revenue in 2023

Figure 19. Amiodarone Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Amiodarone Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Amiodarone Injection Sales Market Share by Country (2019-2030)

Figure 22. North America Amiodarone Injection Revenue Market Share by Country (2019-2030)

Figure 23. U.S. Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Amiodarone Injection Sales Market Share by Country (2019-2030)

Figure 26. Europe Amiodarone Injection Revenue Market Share by Country (2019-2030)

Figure 27. Germany Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Amiodarone Injection Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Amiodarone Injection Revenue Market Share by Region (2019-2030)

Figure 34. China Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Taiwan Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Philippines Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Amiodarone Injection Sales Market Share by Country (2019-2030)

Figure 45. Latin America Amiodarone Injection Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Amiodarone Injection Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Amiodarone Injection Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Amiodarone Injection Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Amiodarone Injection by Type (2019-2030)

Figure 55. Global Revenue Market Share of Amiodarone Injection by Type (2019-2030)

Figure 56. Global Amiodarone Injection Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Amiodarone Injection by Application (2019-2030)

Figure 58. Global Revenue Market Share of Amiodarone Injection by Application (2019-2030)

Figure 59. Global Amiodarone Injection Price (US$/Unit) by Application (2019-2030)

Figure 60. Amiodarone Injection Value Chain

Figure 61. Amiodarone Injection Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions